Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. CSRT.L Share Price
  4. CSRT.L Share Regulatory News
  5. Notice of Results

Pin to quick picksCSRT.L Regulatory News (CSRT)

CSRT.L Information
  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

21 May 2019 16:30

RNS Number : 7498Z
Consort Medical PLC
21 May 2019
 

21 May 2019

 

Consort Medical plc

 

Notice of Results

 

Consort Medical plc (LSE: CSRT) ("Consort", "Consort Medical" or the "Group"), a leading, global, single source drug and delivery device company, will announce its financial results for the year ended 30 April 2019 on Thursday, 13 June 2019.

 

Enquiries: 

 

Consort Medical

Tel: +44 (0) 1442 867920

Jonathan Glenn - Chief Executive Officer

Paul Hayes - Chief Financial Officer

FTI Consulting

Tel: +44 (0) 20 3727 1000

Ben Atwell / Simon Conway

 

About Consort Medical

Consort Medical plc is a leading one-stop developer and manufacturer of drugs and premium drug delivery devices. We partner with pharmaceutical businesses in providing innovative life improving treatments to patients across the world through two integrated activities:

 

The design, development and manufacture of high performance medical devices for inhaled, injectable, nasal and ocular drug delivery, as well as point-of-care diagnostics products.

 

The development, formulation and manufacture of active pharmaceutical ingredients (APIs) and finished dose drugs to the highest quality standards.

 

We employ over 2,000 people globally and are committed to investing in patient, clinician and customer driven innovation to create new treatments.

 

Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT) and is organised in two divisions: Bespak and Aesica. www.consortmedical.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORBSGDURUDBGCB
5678910111213
Date   Source Headline
25th Jul 20197:00 amRNSDirector/PDMR Shareholding
16th Jul 20193:49 pmRNSHolding(s) in Company
15th Jul 20197:00 amRNSIncident at the Aesica Cramlington API Facility
13th Jun 20197:00 amRNSFull Year results
29th May 20198:37 amRNSHolding(s) in Company
28th May 201912:50 pmRNSHolding(s) in Company
21st May 20194:30 pmRNSNotice of Results
15th Apr 20199:21 amRNSBlock listing Interim Review
1st Apr 20199:00 amRNSTotal Voting Rights
19th Mar 20199:14 amRNSHolding(s) in Company
7th Feb 20191:28 pmRNSAGM Voting Update - Director Declaration
31st Jan 20197:00 amRNSDEV610: FDA approval for Mylan's generic Advair
15th Jan 20193:03 pmRNSHolding(s) in Company
2nd Jan 20199:07 amRNSTotal Voting Rights
21st Dec 20187:00 amRNSClosure of American Depositary Receipt Programme
20th Dec 20188:56 amRNSHolding(s) in Company
11th Dec 20189:11 amRNSDirector/PDMR Shareholding
7th Dec 20189:16 amRNSHolding(s) in Company
6th Dec 20185:18 pmRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSInterim Results
3rd Dec 20188:47 amRNSTotal Voting Rights
8th Nov 20183:49 pmRNSDirector/PDMR Shareholding
7th Nov 20182:49 pmRNSHolding(s) in Company
6th Nov 201812:30 pmRNSNotice of Results
6th Nov 20187:00 amRNSDirectorate Change
31st Oct 201811:17 amRNSDirector/PDMR Shareholding
15th Oct 20189:17 amRNSBlock listing Interim Review
10th Oct 20182:24 pmRNSDirector/PDMR Shareholding
9th Oct 201810:46 amRNSDirector/PDMR Shareholding
2nd Oct 201812:57 pmRNSDirector/PDMR Shareholding
1st Oct 20189:08 amRNSTotal Voting Rights
10th Sep 20187:00 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSConsort Signs Development Agreements with Opiant
6th Sep 20183:47 pmRNSDirector/PDMR Shareholding
5th Sep 20184:41 pmRNSResult of AGM
3rd Sep 20188:20 amRNSTotal Voting Rights
23rd Aug 20184:51 pmRNSHolding(s) in Company
22nd Aug 20185:21 pmRNSDirector/PDMR Shareholding
9th Aug 20187:24 amRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Aug 20187:20 amRNSForm 8.5 (EPT/RI) - Carclo Plc
9th Aug 20187:00 amRNSDirector/PDMR Shareholding
8th Aug 20182:58 pmRNSForm 8.3 - Consort Medical Plc
7th Aug 20183:20 pmRNSForm 8.3 - Consort Medical plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
7th Aug 20189:43 amRNSStatement re withdrawal of Consort Medical plc
7th Aug 20188:23 amRNSConsort Medical No Intention to Bid for Carclo plc
6th Aug 20183:11 pmRNSForm 8.3 - Consort Medical PLC
6th Aug 20189:28 amRNSForm 8.3 - Consort Medical plc
3rd Aug 20183:08 pmRNSForm 8.3 - Consort Medical PLC
5678910111213

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.